RF (radiofrequency) energy used to destroy kidney and adrenal tumours
This article was originally published in Clinica
Early results from a US National Institutes of Health (NIH) Clinical Center study look promising for the use of radiofrequency energy in patients with certain kidney and adrenal tumours.
You may also be interested in...
Divesting the heart valve division will allow LivaNova to focus more resources on its neuromodulation, cardiopulmonary and circulatory support businesses.
The US FDA tells manufacturers in two recent warning letters to get to the root cause of contamination problems and take a more proactive approach to cleaning and equipment maintenance.
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.